$VLRX News Article - Valeritas' V-Go Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population
https://marketwirenews.com/news-releases/vale...78464.html